Brief: Aeterna Zentaris And Ceapro Announce Merger Of Equals To Create Diversified Biopharmaceutical Company

Ceapro

14/12/2023 12:58

Dec 14 (Reuters) - Aeterna Zentaris Inc  AEZS.TO :
    * AETERNA ZENTARIS AND CEAPRO ANNOUNCE MERGER OF EQUALS TO
CREATE
A DIVERSIFIED BIOPHARMACEUTICAL COMPANY
    * AETERNA ZENTARIS INC - CEAPRO COMMON SHARE WILL BE
EXCHANGED FOR
0.09439 OF AN AETERNA COMMON SHARE
    * AETERNA ZENTARIS INC: EACH OUTSTANDING CEAPRO COMMON SHARE
WILL
BE EXCHANGED FOR 0.09439 OF AN AETERNA COMMON SHARE
    * AETERNA ZENTARIS INC: CEAPRO WILL BECOME A WHOLLY-OWNED
SUBSIDIARY OF AETERNA
    * AETERNA ZENTARIS INC - FOLLOWING CLOSING OF TRANSACTION,
FORMER
SHAREHOLDERS OF CEAPRO WILL OWN 50% OF AETERNA
    * AETERNA ZENTARIS INC: FOLLOWING CLOSING OF TRANSACTION, IT
IS
EXPECTED THAT SHARES OF COMBINED COMPANY WILL CONTINUE TO TRADE
ON TSX AND NASDAQ
    * AETERNA ZENTARIS INC: CEAPRO AND AETERNA WISH TO ENSURE
THAT
THEIR COMBINED OPERATIONS CAN CONTINUE TO BENEFIT FROM AETERNA
LISTING ON NASDAQ
    * AETERNA ZENTARIS: TO ALLOW AETERNA TO COMPLY WITH NASDAQ'S
STANDARDS AETERNA MAY BE REQUIRED TO COMPLETE CONSOLIDATION OR
REVERSE-SPLIT OF COMMON SHARES
    * AETERNA ZENTARIS-UNDER DEAL CO TO ISSUE TO SHAREHOLDERS
PRIOR TO
DEAL CLOSING, 0.47698 OF SHARE PURCHASE WARRANT FOR EACH CO'S
COMMON SHARE HELD
    * AETERNA ZENTARIS- UPON DEAL BOARD OF DIRECTORS OF COMBINED
CO
WILL CONSIST OF EIGHT DIRECTORS
    * AETERNA ZENTARIS-  CEAPRO'S CEO, GILLES GAGNON, AND
AETERNA'S
CFO, GIULIANO LA FRATTA, CONTINUING TO CARRY OUT
RESPONSIBILITIES UPON CLOSING OF DEAL

Source text for Eikon:  ID:nGNX3gpQR8 
Further company coverage:  AEZS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))